Clinical Trials Sponsored by Center on Addiction

Total 1546 results

Centre for Addiction and Mental Health

Completed

The Family Cognitive Adaptation Training Manual: A Test of Effectiveness

Psychosis

Canada
Centre for Addiction and Mental Health

Completed

Dopamine Release in the Human Brain Following Alcohol Administration

Heavy Drinking

Canada
Centre for Addiction and Mental Health

Withdrawn

Topiramate on Gambling-Related Behaviours

Gambling

Canada
Centre for Addiction and Mental Health

Completed

Electronic Cigarettes in Daily Dependent Smokers

Nicotine Dependence | Substance Withdrawal Syndrome

Canada
Centre for Addiction and Mental Health

Completed

Quetiapine in Co-Morbid Depressive and Anxiety Disorders

Anxiety Disorders | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder | Post-traumatic Stress Disorder | Dysthymic Disorder

Canada
Centre for Addiction and Mental Health

Completed

The Effects of Repetitive Transcranial Magnetic Stimulation in Healthy Human Subjects

Healthy

Canada
Centre for Addiction and Mental Health

Terminated

Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers

Alcohol Dependence

Canada
Centre for Addiction and Mental Health

Terminated

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia (NIC-PAS)

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Yoga in Unipolar and Bipolar Disorders

Bipolar Disorder | Major Depression | Dysthymia

Canada
Centre for Addiction and Mental Health

Completed

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

Schizophrenia | Cigarette Smoking

Canada
Centre for Addiction and Mental Health

Completed

A Personalized Feedback Intervention for Problem Gamblers

Problem Gambling

Canada
Centre for Addiction and Mental Health

Completed

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide

Hypersalivation

Canada
Centre for Addiction and Mental Health

Completed

Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

Concurrent Alcohol Dependence and Pathological Gambling

Canada, Finland
Centre for Addiction and Mental Health

Recruiting

Cognitive Dysfunction in the Addictions Study - Project 4 (P4) (CDiA-P4)

Major Depressive Disorder | Alcohol Use Disorder

Canada
Centre for Addiction and Mental Health

Not yet recruiting

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD (PAP-OCD)

Obsessive-Compulsive Disorder
Centre for Addiction and Mental Health

Not yet recruiting

Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

Schizophrenia | Schizophreniform Disorders

Canada
Centre for Addiction and Mental Health

Recruiting

Effects of Antipsychotics on Brain Insulin Action in Females

Insulin Resistance | Type 2 Diabetes | Menstrual Cycle | Antipsychotics

Canada
Centre for Addiction and Mental Health

Recruiting

Presynaptic Imaging in Major Depressive Episodes After COVID-19 (PCOV)

Major Depressive Disorder | Long COVID | Major Depressive Episode

Canada
Centre for Addiction and Mental Health

Recruiting

Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

Amnestic Mild Cognitive Impairment

Canada
Centre for Addiction and Mental Health

Recruiting

Investigating the Effects of Nabilone on Endocannabinoid Metabolism (NABI)

Healthy

Canada
Centre for Addiction and Mental Health

Recruiting

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Healthy | Schizophrenia

Canada
Centre for Addiction and Mental Health

Recruiting

Does Psilocybin Require Psychedelic Effects to Treat Depression? (PSI-RIS)

Treatment-resistant Depression

Canada
Centre for Addiction and Mental Health

Recruiting

Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder

Stress Disorders, Post-Traumatic | Alcohol Use Disorder

Canada
Centre for Addiction and Mental Health

Not yet recruiting

Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes (CASE-CT)

Driving Under the Influence
Centre for Addiction and Mental Health

Recruiting

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity (Sema)

Schizophrenia Spectrum Disorders

Canada
Centre for Addiction and Mental Health

Recruiting

Effect of Extended Cannabis Abstinence on PTSD Symptoms (CANPOST)

PTSD | Cannabis Use | Cognitive Symptom | Comorbidities and Coexisting Conditions

Canada
Centre for Addiction and Mental Health

Recruiting

Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3) (DB3)

Bipolar Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar Disorder (DB1)

Bipolar Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Accelerated TBS in Late Life Depression

Treatment Resistant Depression

Canada
Centre for Addiction and Mental Health

Recruiting

Group Intervention to Improve Parent-Adolescent Relationships

Depression

Canada
Centre for Addiction and Mental Health

Recruiting

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Schizophrenia;Schizoaffective

Canada
Centre for Addiction and Mental Health

Active, not recruiting

Neuroinflammation in COVID-19 and Depression

Covid19 | Major Depressive Episode

Canada
Centre for Addiction and Mental Health

Completed

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia

Healthy | Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

A Dietary Supplement for Mood Symptoms in Early Postpartum: A Double Blind Randomized Placebo Controlled Trial

Healthy | Postpartum Blues

Canada
Centre for Addiction and Mental Health

Completed

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia (rTMSCANSZ)

Schizophrenia | Cognition | Cannabis Use Disorder | Repetitive Transcranial Magnetic Stimulation (rTMS)

Canada
Centre for Addiction and Mental Health

Completed

Effects of Cannabis Abstinence on Symptoms and Cognition in Depression

Major Depressive Disorder | Cognition | Cannabis Use Disorder

Canada
Centre for Addiction and Mental Health

Completed

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders) (SURE-ECT)

Depression

Canada
Centre for Addiction and Mental Health

Completed

Role of BP1.3656 on Alcohol Responses

Alcohol Use Disorder

Canada
Centre for Addiction and Mental Health

Completed

Targeting Mailed Nicotine Patch Distribution Interventions to Rural Regions of Canada

Tobacco Use Cessation

Canada
Centre for Addiction and Mental Health

Completed

Dose-response of Cannabis and Driving

Cognitive Impairment | Driving Impaired | Abuse Cannabis

Canada
Centre for Addiction and Mental Health

Completed

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Delusional Disorder | Psychotic Disorder

Canada
Centre for Addiction and Mental Health

Completed

Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates

Tobacco Use Cessation

Canada
Centre for Addiction and Mental Health

Completed

Xyrem and Brain Dopamine in Narcolepsy

Healthy Controls | Narcolepsy With Cataplexy

Canada
Centre for Addiction and Mental Health

Completed

Personalized Feedback Intervention to Reduce Risky Cannabis Use.

Cannabis Use

Canada
Centre for Addiction and Mental Health

Completed

Non-invasive Brain Stimulation Using Transcranial Direct Current Stimulation for Neuropsychiatric Symptoms of Dementia

Dementia; Alzheimer, Mixed Type (Etiology)

Canada
Centre for Addiction and Mental Health

Completed

Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum

Schizophrenia Spectrum and Other Psychotic Disorders

Canada
Centre for Addiction and Mental Health

Unknown

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
Centre for Addiction and Mental Health

Completed

Neuroimaging MAO-B in Medication Free TR-MDD Using Novel Tracer (DETB)

Major Depressive Disorder

Canada
Centre for Addiction and Mental Health

Completed

Transdiagnostic iCBT for Depression and Anxiety

Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder

Canada
Centre for Addiction and Mental Health

Completed

Melatonin Use for Sleep Problems in Alcohol Dependent Patients

Alcohol-Related Disorders

Canada

Clinical Trials Sponsored by Center on Addiction

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations